|
gptkbp:instanceOf
|
gptkb:United_States_federal_law
|
|
gptkbp:abbreviation
|
gptkb:FDASIA
|
|
gptkbp:amendedBy
|
gptkb:Federal_Food,_Drug,_and_Cosmetic_Act
|
|
gptkbp:containsProvision
|
provisions for antibiotic development
provisions for drug shortages
provisions for medical device regulation
provisions for rare diseases
user fee programs for drugs and medical devices
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:enactedBy
|
gptkb:United_States_Congress
|
|
gptkbp:fullName
|
gptkb:Food_and_Drug_Administration_Safety_and_Innovation_Act
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
FDASIA
|
|
gptkbp:publicLawNumber
|
gptkb:Public_Law_112-144
|
|
gptkbp:purpose
|
to expand the authority and resources of the FDA
|
|
gptkbp:regulates
|
gptkb:Food_and_Drug_Administration
|
|
gptkbp:signedBy
|
gptkb:Barack_Obama
July 9, 2012
|
|
gptkbp:subjectArea
|
gptkb:drug
public health
medical device
|
|
gptkbp:title
|
gptkb:Food_and_Drug_Administration_Safety_and_Innovation_Act
|
|
gptkbp:bfsParent
|
gptkb:Food_and_Drug_Administration_Safety_and_Innovation_Act
|
|
gptkbp:bfsLayer
|
6
|